The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Empagliflozin

Australian Public Assessment Report

AusPAR

AusPAR: Empagliflozin [Jardiance] [PDF, 1.31 MB]

AusPAR: Empagliflozin [Jardiance] [Word, 7.2 MB]

Attachment: Product Information: Empagliflozin [Jardiance] [PDF, 465.1 KB]

Attachment: Product Information: Empagliflozin [Jardiance] [Word, 485.33 KB]

Attachment: Extract from Clinical Evaluation Report: Empagliflozin [Jardiance] [PDF, 2.06 MB]

Attachment: Extract from Clinical Evaluation Report: Empagliflozin [Jardiance] [Word, 6.79 MB]

Device/Product Name

Jardiance

Active ingredients

Empagliflozin

AusPAR Date

26 October 2017

Published

8 November 2017

Submission Number

PM-2015-04356-1-5

Submission Type

Extension of indications

Decision

Approved